Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Moderna, Inc. Transaction History

Mitsubishi Ufj Morgan Stanley Securities Co., Ltd.

  • $7.89 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$118.38 - $210.04 $3,551 - $6,301
-30 Reduced 60.0%
20 $4,000
Q1 2022

May 04, 2022
SELL
$126.46 - $235.05 $95,603 - $177,697
-756 Reduced 93.8%
50 $9,000
Q4 2021

Feb 10, 2022
BUY
$225.82 - $368.51 $130,072 - $212,261
576 Added 250.43%
806 $205,000
Q3 2021

Nov 12, 2021
BUY
$221.9 - $484.47 $51,037 - $111,428
230 New
230 $89,000

Others Institutions Holding MRNA

# of Institutions
954
Shares Held
241M
Call Options Held
10.6M
Put Options Held
18.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. Portfolio

Follow Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Morgan Stanley Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Morgan Stanley Securities Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email